428 related articles for article (PubMed ID: 25052427)
1. The use of spirocyclic scaffolds in drug discovery.
Zheng Y; Tice CM; Singh SB
Bioorg Med Chem Lett; 2014 Aug; 24(16):3673-82. PubMed ID: 25052427
[TBL] [Abstract][Full Text] [Related]
2. The utilization of spirocyclic scaffolds in novel drug discovery.
Zheng YJ; Tice CM
Expert Opin Drug Discov; 2016 Sep; 11(9):831-4. PubMed ID: 27233084
[No Abstract] [Full Text] [Related]
3. Spirocyclic Scaffolds in Medicinal Chemistry.
Hiesinger K; Dar'in D; Proschak E; Krasavin M
J Med Chem; 2021 Jan; 64(1):150-183. PubMed ID: 33381970
[TBL] [Abstract][Full Text] [Related]
4. Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase.
Keith JM; Jones WM; Pierce JM; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Scott BP; Wilson SJ; Luo L; Wennerholm ML; Chang L; Brown SM; Rizzolio M; Rynberg R; Chaplan SR; Breitenbucher JG
Bioorg Med Chem Lett; 2014 Feb; 24(3):737-41. PubMed ID: 24433863
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of privileged scaffolds by using diversity-oriented synthesis.
Surakanti R; Sanivarapu S; Thulluri C; Iyer PS; Tangirala RS; Gundla R; Addepally U; Murthy YL; Velide L; Sen S
Chem Asian J; 2013 Jun; 8(6):1168-76. PubMed ID: 23512685
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a family of spirocyclic scaffolds: building blocks for the exploration of chemical space.
Kumar S; Thornton PD; Painter TO; Jain P; Downard J; Douglas JT; Santini C
J Org Chem; 2013 Jul; 78(13):6529-39. PubMed ID: 23758452
[TBL] [Abstract][Full Text] [Related]
7. Molecular diversity of spirooxindoles. Synthesis and biological activity.
Pavlovska TL; Redkin RG; Lipson VV; Atamanuk DV
Mol Divers; 2016 Feb; 20(1):299-344. PubMed ID: 26419598
[TBL] [Abstract][Full Text] [Related]
8. Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1,2,4-trioxolanes.
Dong Y; Tang Y; Chollet J; Matile H; Wittlin S; Charman SA; Charman WN; Tomas JS; Scheurer C; Snyder C; Scorneaux B; Bajpai S; Alexander SA; Wang X; Padmanilayam M; Cheruku SR; Brun R; Vennerstrom JL
Bioorg Med Chem; 2006 Sep; 14(18):6368-82. PubMed ID: 16759871
[TBL] [Abstract][Full Text] [Related]
9. Advances in Spirocyclic Hybrids: Chemistry and Medicinal Actions.
Benabdallah M; Talhi O; Nouali F; Choukchou-Braham N; Bachari K; Silva AMS
Curr Med Chem; 2018; 25(31):3748-3767. PubMed ID: 29521213
[TBL] [Abstract][Full Text] [Related]
10. Trianion synthon approach to spirocyclic heterocycles.
Perry MA; Hill RR; Rychnovsky SD
Org Lett; 2013 May; 15(9):2226-9. PubMed ID: 23594129
[TBL] [Abstract][Full Text] [Related]
11. New and unusual scaffolds in medicinal chemistry.
Marson CM
Chem Soc Rev; 2011 Nov; 40(11):5514-33. PubMed ID: 21837344
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds.
Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Walker MC; Schweitzer BA; Madsen HM; Tenbrink RE; McDonald J; Smith SE; Foltin S; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2011 Nov; 21(21):6538-44. PubMed ID: 21924614
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Multifunctional Spirocyclic Azetidines and Their Application in Drug Discovery.
Kirichok AA; Shton IO; Pishel IM; Zozulya SA; Borysko PO; Kubyshkin V; Zaporozhets OA; Tolmachev AA; Mykhailiuk PK
Chemistry; 2018 Apr; 24(21):5444-5449. PubMed ID: 29338097
[TBL] [Abstract][Full Text] [Related]
14. Charting Biologically Relevant Spirocyclic Compound Space.
Müller G; Berkenbosch T; Benningshof JC; Stumpfe D; Bajorath J
Chemistry; 2017 Jan; 23(3):703-710. PubMed ID: 27859909
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of oxaspirannic building blocks by regioselective nitroso-Diels-Alder reactions.
Sancibrao P; Gori D; Kouklovsky C; Vincent G
Chemistry; 2013 Apr; 19(18):5557-60. PubMed ID: 23508771
[TBL] [Abstract][Full Text] [Related]
16. Recent
Batista VF; Pinto DCGA; Silva AMS
Expert Opin Drug Discov; 2022 Jun; 17(6):603-618. PubMed ID: 35333138
[TBL] [Abstract][Full Text] [Related]
17. Fsp
Wei W; Cherukupalli S; Jing L; Liu X; Zhan P
Drug Discov Today; 2020 Oct; 25(10):1839-1845. PubMed ID: 32712310
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of C-xylopyranosyl- and xylopyranosylidene-spiro-heterocycles as potential inhibitors of glycogen phosphorylase.
Somsák L; Bokor É; Czibere B; Czifrák K; Koppány C; Kulcsár L; Kun S; Szilágyi E; Tóth M; Docsa T; Gergely P
Carbohydr Res; 2014 Nov; 399():38-48. PubMed ID: 25081322
[TBL] [Abstract][Full Text] [Related]
19. Doubly dearomatising intramolecular coupling of a nucleophilic and an electrophilic heterocycle.
Brice H; Clayden J
Chem Commun (Camb); 2009 Apr; (15):1964-6. PubMed ID: 19333458
[TBL] [Abstract][Full Text] [Related]
20. The activity of dispiro peroxides against Fasciola hepatica.
Wang X; Zhao Q; Vargas M; Dong Y; Sriraghavan K; Keiser J; Vennerstrom JL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5320-3. PubMed ID: 21802291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
